ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,094,492 | -53.0% | 305,478 | -54.1% | 0.01% | -64.5% |
Q3 2022 | $6,581,000 | +222.3% | 665,422 | +246.9% | 0.03% | +244.4% |
Q2 2022 | $2,042,000 | +107.3% | 191,799 | +290.1% | 0.01% | +200.0% |
Q3 2021 | $985,000 | -2.4% | 49,165 | +7.2% | 0.00% | -25.0% |
Q2 2021 | $1,009,000 | -34.4% | 45,857 | +1.2% | 0.00% | -42.9% |
Q1 2021 | $1,539,000 | – | 45,305 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |